Clinical Trials Browser

OTHER × Aspirin × Myeloid × Clear all

NCT05198960 2025-02-04

AVAJAK

Phase 3 Recruiting

Classical hematologyMyeloid

Hemorrhage, Polycythemia Vera, Thrombocythemia, Essential, Venous Thromboembolism, Primary Myelofibrosis

NCT04160546 2024-12-31

ResToP

Phase 2 Active not recruiting

MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Chronic-Phase

NCT03003325 2024-09-19

Low-PV

Phase 2 Completed

Polycythemia Vera

NCT04243122 2024-05-29

AIRPORT-MPN

Phase 2 Completed

Classical hematologyMyeloid

Myeloproliferative Disorders, Polycythemia Vera, Thrombocythemia, Essential, Venous Thromboembolism, Primary Myelofibrosis

NCT01259817 2017-01-11

Pegylated Interferon Alfa-2a Salvage Therapy in High Risk Polycythemia Vera (PV) or Essential Thrombocythemia (ET)

Phase 2 Completed

Polycythemia Vera, Thrombocythemia, Essential

NCT00940784 2014-11-26

ISCLAP

Phase 2 Withdrawn

Polycythemia Vera